Global Fair Pricing Tensions

Posted by Ed Schoonveld on Thu, May 16, 2019

Pricing for prescription drugs has been a contentious issue around the world as payers and patients don’t understand the cause of high drug prices and are struggling with patient access. Particularly in middle- and low-income countries, affordability of drugs in cancer has become an important part of a dialogue between the World Health Organization, governments, non-governmental organizations and patient advocates. The WHO has organized several meetings to explore and drive resolutions for drug-pricing-related issues for patented and generic drugs.


>
Read More

The UK's Pay-or-Play Solution: A Horribly Flawed Idea

Posted by Ed Schoonveld on Fri, May 20, 2016

We desperately need new anti-infective drugs to avoid life threatening infections! Let’s make that happen by punishing companies who don’t invest in R&D for these specific drugs.

No, this is not a bad joke, but rather a slightly paraphrased recommendation of a U.K. government-commissioned Review of Antimicrobial Resistance (AMR). Let’s look at the details.


>
Read More